A detailed history of Martin Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Martin Capital Partners, LLC holds 180,281 shares of PFE stock, worth $5.04 Million. This represents 1.92% of its overall portfolio holdings.

Number of Shares
180,281
Previous 83,582 115.69%
Holding current value
$5.04 Million
Previous $2.41 Million 107.94%
% of portfolio
1.92%
Previous 0.98%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 05, 2024

BUY
$25.89 - $29.73 $2.5 Million - $2.87 Million
96,699 Added 115.69%
180,281 $5 Million
Q4 2023

Jan 05, 2024

SELL
$26.13 - $33.94 $493,647 - $641,194
-18,892 Reduced 18.44%
83,582 $2.41 Million
Q3 2023

Oct 13, 2023

BUY
$32.09 - $37.51 $95,146 - $111,217
2,965 Added 2.98%
102,474 $3.4 Million
Q2 2023

Jul 17, 2023

SELL
$36.12 - $41.79 $26,006 - $30,088
-720 Reduced 0.72%
99,509 $3.65 Million
Q1 2023

Apr 05, 2023

SELL
$39.39 - $51.28 $2.57 Million - $3.35 Million
-65,251 Reduced 39.43%
100,229 $4.09 Million
Q4 2022

Jan 05, 2023

SELL
$41.75 - $54.5 $477,494 - $623,316
-11,437 Reduced 6.46%
165,480 $8.48 Million
Q3 2022

Oct 06, 2022

BUY
$43.76 - $53.42 $1.58 Million - $1.93 Million
36,218 Added 25.74%
176,917 $7.74 Million
Q2 2022

Jul 08, 2022

BUY
$46.53 - $55.17 $315,845 - $374,493
6,788 Added 5.07%
140,699 $7.38 Million
Q1 2022

Apr 06, 2022

SELL
$45.75 - $56.69 $2.29 Million - $2.84 Million
-50,070 Reduced 27.21%
133,911 $6.93 Million
Q4 2021

Jan 07, 2022

BUY
$41.32 - $61.25 $12,272 - $18,191
297 Added 0.16%
183,981 $10.9 Million
Q3 2021

Oct 06, 2021

BUY
$39.25 - $50.42 $171,758 - $220,637
4,376 Added 2.44%
183,684 $7.9 Million
Q2 2021

Jul 06, 2021

BUY
$35.91 - $40.68 $73,615 - $83,394
2,050 Added 1.16%
179,308 $7.02 Million
Q1 2021

Apr 14, 2021

BUY
$33.49 - $37.77 $261,690 - $295,134
7,814 Added 4.61%
177,258 $6.42 Million
Q4 2020

Jan 07, 2021

SELL
$33.47 - $42.56 $79,424 - $100,994
-2,373 Reduced 1.38%
169,444 $6.24 Million
Q3 2020

Oct 08, 2020

SELL
$31.75 - $37.25 $113,474 - $133,131
-3,574 Reduced 2.04%
171,817 $6.31 Million
Q2 2020

Jul 07, 2020

SELL
$30.12 - $36.54 $83,673 - $101,508
-2,778 Reduced 1.56%
175,391 $5.74 Million
Q1 2020

Apr 21, 2020

SELL
$27.03 - $38.62 $125,959 - $179,969
-4,660 Reduced 2.55%
178,169 $5.82 Million
Q4 2019

Jan 31, 2020

BUY
$32.92 - $37.36 $348,984 - $396,053
10,601 Added 6.16%
182,829 $7.16 Million
Q3 2019

Nov 20, 2019

BUY
$32.49 - $42.13 $935,127 - $1.21 Million
28,782 Added 20.06%
172,228 $6.19 Million
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $215,593 - $242,061
5,830 Added 4.24%
143,446 $6.21 Million
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $586,125 - $643,956
15,630 Added 12.81%
137,616 $5.85 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $197,235 - $224,870
5,127 Added 4.39%
121,986 $5.33 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $91,724 - $111,256
2,661 Added 2.33%
116,859 $5.15 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $189,898 - $202,451
-5,758 Reduced 4.8%
114,198 $4.14 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $109,578 - $127,126
3,434 Added 2.95%
119,956 $4.26 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $3.88 Million - $4.11 Million
116,522
116,522 $4.22 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Martin Capital Partners, LLC Portfolio

Follow Martin Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Martin Capital Partners, LLC with notifications on news.